Jackie Fortier
👤 SpeakerAppearances Over Time
Podcast Appearances
Starting July 1st, GLP-1 medications like Wegovy and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
The program will cap the monthly cost of the popular drugs at $50.
Without insurance, these drugs currently cost hundreds of dollars.
To qualify, people need a doctor's note and Medicare Part D.
They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.
The $50 copay won't count toward the annual out-of-pocket limit.
The pilot also expires in December 2027, with no guarantee that the drugs will be covered under traditional Medicare after it ends.
Starting July 1st, GLP-1 medications like Wegovi and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
The program will cap the monthly cost of the popular drugs at $50.
Without insurance, these drugs currently cost hundreds of dollars.
To qualify, people need a doctor's note and Medicare Part D. They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.
The $50 copay won't count toward the annual out-of-pocket limit.
The pilot also expires in December 2027, with no guarantee that the drugs will be covered under traditional Medicare after it ends.
That's Jackie Fortier reporting.
Starting July 1st, GLP-1 medications like Wegovi and Zepbound will be available to some Medicare enrollees for weight loss for the first time.
To qualify, people need a doctor's note and Medicare Part D. They also need to be clinically overweight, plus have a condition like heart disease or prediabetes.